Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05044624
Other study ID # IMU2021
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 1, 2016
Est. completion date June 1, 2021

Study information

Verified date September 2021
Source Istanbul Medeniyet University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

: Soft Tissue Sarcomas are rare mesenchymal tumors with many subtypes. Clean margin-wide resection is recommended for treatment. The guidelines recommend that sarcoma treatments be carried out in sarcoma centers. In this study, the location, histopathological features, clinical and demographic features, recurrence, and prognosis of retroperitoneal sarcomas were investigated.


Description:

The demographic, histopathological, and immunohistochemical data of the patients who were operated on with the diagnosis of intraabdominal mass at Istanbul Medeniyet University Göztepe Prof. Dr. Süleyman Yalçın City Hospital from March 2016 to December 2020 were retrospectively evaluated. Ethical approval was obtained from Istanbul Medeniyet University Göztepe Prof. Dr. Süleyman Yalçın City Hospital Ethics Committee. Patients diagnosed with pathological sarcoma subclass were included in the study. Patients younger than 18 years were excluded from the study. Visceral organ-origin sarcomas and extremity sarcomas were also excluded from the study. GIST's were included in sarcoma subtypes by WHO in 2013. However, they were not included in the study due to their solid organ origin. The data of 18 patients' whore remained after the exclusion criteria were analyzed retrospectively. Pathology samples of the patients were re-examined by a single pathologist. The demographic analysis was used for statistics.


Recruitment information / eligibility

Status Completed
Enrollment 18
Est. completion date June 1, 2021
Est. primary completion date June 1, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients operated with the diagnosis of intra-abdominal mass - patients diagnosed with pathological sarcoma subclasses Exclusion Criteria: - Patients younger than 18 years - Visceral organ-origin sarcomas - extremity sarcomas - GIST

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
retroperitoneal mass excision
retroperitoneal mass excision

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Istanbul Medeniyet University

Outcome

Type Measure Description Time frame Safety issue
Primary Clean margin wide resection effect of clean surgical margin on recurrence 63 month
See also
  Status Clinical Trial Phase
Recruiting NCT03838718 - REtroperitoneal SArcoma Registry: an International Prospective Initiative
Enrolling by invitation NCT05844813 - Neoadjuvant Chemotherapy Combined With Targeted Treatment in High-risk Retroperitoneal Sarcoma Phase 4
Terminated NCT00901836 - Preoperative Proton Radiotherapy for Retroperitoneal Sarcoma N/A
Active, not recruiting NCT04189783 - Repeat or Single Quadratus Lumborum Block for the Reduction of Opioid Prescriptions After Surgery in Retroperitoneal Sarcoma Patients ("RESQU-SARC" Trial) Phase 2
Completed NCT04225494 - Perioperative Residual Adrenal Function After Extended Resection for Retroperitoneal Soft Tissue Sarcomas
Active, not recruiting NCT03792867 - Radical Resection and HIPEC for Recurrent Retroperitoneal Sarcoma N/A
Not yet recruiting NCT06025747 - Evaluation of Abemaciclib and Radiation Therapy Before Surgery for the Treatment of High-Risk Adipocytic Retroperitoneal Sarcoma Phase 1
Active, not recruiting NCT04224948 - The PET- Retroperitoneal Sarcoma Study N/A
Recruiting NCT04031677 - Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma Phase 3
Recruiting NCT05224934 - Preoperative Ultra-hypofractionated Radiotherapy Followed by Surgery for Retroperitoneal Sarcoma Phase 2
Completed NCT03877588 - Nutritional Status in Retroperitoneal Sarcoma. N/A
Completed NCT02384473 - Real-Time Contrast-Enhanced Ultrasonography and Shear Wave Elastography in Predicting Treatment Response in Patients With Soft Tissue Sarcoma Early Phase 1
Withdrawn NCT05302570 - Neoadjuvant Short-course Hypofractionated PBT for Non-metastatic RPS Phase 2
Recruiting NCT01659203 - Proton or Photon RT for Retroperitoneal Sarcomas Phase 1/Phase 2
Recruiting NCT05631379 - Influence of Nutritional Status on Oncologic and Operative Outcome in Patients Operated for Retroperitoneal Sarcoma
Recruiting NCT06327477 - Proton-Spatially Fractionated Radiotherapy and Standard Radiation Therapy for the Treatment of Newly Diagnosed Retroperitoneal Soft Tissue Sarcoma Phase 1/Phase 2